EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Non-Invasive Transtympanic Bioadhesive Hydrogel for Sustained Delivery of Dexamethasone in Otitis Media Effusion Therapy

Qian Wan, Hanwei Liu, Shizhe Sun, Ruotong Wang, Jingwei Lai, Wendi Shi, Yuanyuan Xu, Yumeng Jiang, Xianchuang Hu, Ziyuan Li, Minhui Zhu, Junji Zhang iD und 1 weitere

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c07256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Qian Wan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head & Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicin…. Hauptthemen laut MEDLINE: Dexamethasone, Otitis Media with Effusion, Hydrogels, Drug Delivery Systems. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Natural Science Foundation Project, National Key Research and Development Project of the Ministry of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Otitis media with effusion (OME) is a highly prevalent condition characterized by persistent inflammatory effusion in the middle ear cavity. The clinical management of OME remains challenging due to the anatomical inaccessibility of the middle ear, which limits drug efficacy and often necessitates invasive surgical interventions. To address this, we engineered a transtympanic hydrogel platform (Gel-HADA) that undergoes rapid, enzyme-mediated gelation on the tympanic membrane (TM), forming a “second membrane” through transglutaminase (TGase) crosslinking within 15 min. This hydrogel adheres firmly to the TM, degrades controllably to 5.4 ± 4.0% remaining mass over 7 days, and provides sustained drug delivery. As a result, dexamethasone phosphate disodium-loaded Gel-HADA (Gel-HADA-Dex) demonstrated effective permeability across ex vivo rat TM. In a rat OME model, a single Gel-HADA-Dex administration effectively suppressed mucosal inflammation and restored middle ear function (100% Type A curves, equivalent to the healthy control group). TM thickness (from 91.40 ± 16.46 μm to 8.32 ± 1.60 μm), mucosal thickness (from 67.97 ± 6.21 μm to 46.50 ± 2.47 μm), and leukocyte counts in middle ear lavage (from 140.37 ± 45.94 /HPF to 11.07 ± 1.76 /HPF) were significantly reduced. Mechanistically, Gel-HADA-Dex normalized the aberrant immune-transcriptional network and suppressed key pro-inflammatory cytokines while enhancing anti-inflammatory mediators. The hydrogel demonstrated excellent biocompatibility, hemocompatibility, and auditory safety. Together, the study established Gel-HADA as an innovative, rapid in situ enzymatically crosslinked system for non-invasive transtympanic corticosteroid delivery. Ultimately, it provides a reliable and potentially clinically translatable strategy for localized treatment of OME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneOtitis Media with EffusionHydrogelsDrug Delivery SystemsAnimalsRatsRats, Sprague-DawleyTympanic MembraneMaleHumansDelayed-Action Preparations

Stichwörter der Autor:innen

bioadhesive hydrogelenzyme-mediated gelationnon-invasivenessotitis media effusiontranstympanic delivery

Substanzen

DexamethasoneHydrogelsDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Otorhinolaryngology Head & Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai200233, China.
  • Institute of Fine Chemicals, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai200237, China.
  • Hangzhou Ren-Ai Hearing Rehabilitation Research Center, Hui'er Artificial Intelligence Hearing Research Center, Hangzhou310011, China.
  • Department of Otorhinolaryngology Head & Neck Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai Changhai Hospital, Shanghai200433, China.

ORCID-Profile: Junji Zhang, Haibo Shi

Förderung

  • National Natural Science Foundation of China
  • Shanghai Natural Science Foundation Project
  • National Key Research and Development Project of the Ministry of Science and Technology

Zitieren

APA

Wan, Q., Liu, H., Sun, S., Wang, R., Lai, J., Shi, W., Xu, Y., Jiang, Y., Hu, X., Li, Z., Zhu, M., Zhang, J., & Shi, H. (2026). A Non-Invasive Transtympanic Bioadhesive Hydrogel for Sustained Delivery of Dexamethasone in Otitis Media Effusion Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c07256

Vancouver

Wan Q, Liu H, Sun S, Wang R, Lai J, Shi W, et al. A Non-Invasive Transtympanic Bioadhesive Hydrogel for Sustained Delivery of Dexamethasone in Otitis Media Effusion Therapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c07256

BibTeX
@article{Wan2026,
  author = {Wan, Qian and Liu, Hanwei and Sun, Shizhe and Wang, Ruotong and Lai, Jingwei and Shi, Wendi and Xu, Yuanyuan and Jiang, Yumeng and Hu, Xianchuang and Li, Ziyuan and Zhu, Minhui and Zhang, Junji and Shi, Haibo},
  title = {A Non-Invasive Transtympanic Bioadhesive Hydrogel for Sustained Delivery of Dexamethasone in Otitis Media Effusion Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c07256}
}
Kostenlos starten →